Pre-clinical studies suggested DHA might contribute to recovering the normal function of DA neurons through slowing down the DA metabolism in Parkinsonism-like models [44], and DAT downregulation might be an indicator of slowed DA metabolism [45]. This evidence concerns the gene SLC6A3 and Parkinson disease.